# POTASSIUM PHOSPHATES
> **NDA212121** · New Drug Application · Sponsor: CMP DEV LLC · Approved 2019-09-19
## Drug
- **FDA Application Number:** NDA212121
- **Application type:** New Drug Application
- **Brand name:** POTASSIUM PHOSPHATES
- **Generic name:** Potassium Phosphate, Dibasic
- **Active ingredients:** POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** CMP DEV LLC
- **First approval:** 2019-09-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212121)
---
*AI Analytics · CC0 1.0*